[Church of England] The Church of England national investing bodies will actively use their position as investors to encourage a precautionary approach to genetic modification, having adopted an updated and more detailed ethical investment policy on genetically modified organisms.

The policy, on the advice of the Church’s Ethical Investment Advisory Group, allows for investment in companies developing and marketing GMOs where there is satisfactory assurance on, and confidence in, ethical standards. Agricultural land and timberland will have to pass genetic-modification due-diligence tests to be included in investments. The conduct of genetic-modification field trials on land owned by the national investing bodies would be inconsistent with the policy.

“There is no single Christian perspective on genetic modification,” said James Featherby, advisory group chair. “The EIAG recognizes the potential benefits of responsibly conducted [genetic modification] such as pest resistance, vitamin supply and improved resilience to drought, frost and saline conditions.

“We are also conscious that genetic modification represents a paradigm shift in plant and animal breeding and that there remain uncertainties about the effects of the application of the technology.

“The EIAG concluded that it is important that the investment practice of the national investing bodies should be consistent with a careful and precautionary approach to genetic modification.”

The policy sets down detailed guidelines on how the investing bodies should judge whether a company developing and marketing GMOs is operating in an ethically appropriate and duly precautionary way.

It also sets out detailed guidelines for decision-making on exposure to GMOs through agricultural land and timberland.

The Church Commissioners for England are significant landowners in the United Kingdom. However, the European Union and its member states continue to take a restrictive approach to genetic modification, and there is no commercial planting of genetically modified crops in the United Kingdom.

In 2000, the EIAG advised the commissioners (and other church landowners, such as dioceses) against approving genetic-modification trials on their farmland. The updated policy announced today advises that the cultivation of genetically modified crops on land owned by the national investing bodies should be restricted to “well established GMOs that are broadly accepted in the country concerned.”

Ethical investment policies are published here. The policy on GMOs is here.

The Church of England Ethical Investment Advisory Group makes recommendations on ethical investment policy to the church’s three national investing bodies: the commissioners, the Church of England Pensions Board and the CBF Church of England Funds managed by CCLA. Together they hold assets in excess of £8 billion ($12.10 billion).

The EIAG includes representation from the General Synod, the Archbishops’ Council and the Council for Mission and Public Affairs as well as the investing bodies.